Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M393Revenue (TTM) $M7.1Net Margin (%)-276.0Altman Z-Score8.8
Enterprise Value $M374EPS (TTM) $-0.3Operating Margin %-1,083.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-540.2Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %32.4Quick Ratio4.2Cash flow > EarningsN
Price/Sales45.85-y EBITDA Growth Rate %28.0Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-22.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-65.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M103ROIC % (ttm)-187.1Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-06-21Buy2,732,636$2.3959view
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-01-20Buy300,000$2.3561.7view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2016-01-20Sell300,000$2.3561.7view
FARRELL STEPHEN CDirector 2015-11-06Buy50,000$3.83-0.78view
Russell Angus C.Director 2015-11-06Buy50,000$3.83-0.78view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2015-11-06Sell100,000$3.83-0.78view
ANDREWS DEBORAH JDirector 2015-08-26Buy2,000$2.8234.75view
Cartt Stephen LaHueDirector 2015-08-18Buy75,000$2.835.71view
Russell Angus C.Director 2014-12-12Sell0$035.71view
Cartt Stephen LaHueDirector 2014-11-04Sell0$035.71view

Quarterly/Annual Reports about BTX:

News about BTX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

More From Other Websites
Coverage initiated on BioTime by Ladenburg Thalmann Sep 23 2016
BioTime to Webcast Presentation at the Ladenburg Thalmann 2016 Healthcare Conference Sep 23 2016
This Historic Medical Breakthrough Is a Game Changer for Biotech Sep 19 2016
BioTime Affiliate, Asterias Biotherapeutics, Announced Positive Interim Efficacy Data From Trial in... Sep 15 2016
BioTime Affiliate, Asterias Biotherapeutics, Announced Positive Interim Efficacy Data From Trial in... Sep 15 2016
BIOTIME INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 14 2016
ETF’s with exposure to BioTime, Inc. : September 9, 2016 Sep 09 2016
BioTime to Present at Two Upcoming Investor Conferences Sep 06 2016
BioTime to Present at Two Upcoming Investor Conferences Sep 06 2016
BioTime, Inc. breached its 50 day moving average in a Bullish Manner : BTX-US : August 31, 2016 Aug 31 2016
BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Aug 29 2016
ETF’s with exposure to BioTime, Inc. : August 29, 2016 Aug 29 2016
BIOTIME INC Financials Aug 18 2016
Asterias Biotherapeutics Reports Second Quarter Results and Highlights Progress of SCiSTAR Study... Aug 15 2016
ETF’s with exposure to BioTime, Inc. : August 15, 2016 Aug 15 2016
BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative... Aug 15 2016
BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative... Aug 15 2016
BioTime, Inc. :BTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
BioTime, Inc. Reports Second Quarter Results and Recent Corporate Accomplishments Aug 09 2016
BIOTIME INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)